Study the effectiveness of outpateint treatment of cystic fibrosis exacerbatio
Phase 2
- Conditions
- Cystic Fibrosis.Cystic fibrosis
- Registration Number
- IRCT20191112045413N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
Documented diagnosis of CF
Exacerbation phase
Older than 6 years
Exclusion Criteria
Patients unable to perform pulmonary tests because of physical or mental limitations
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent of patients with increased FEV1 values. Timepoint: Before initiation of outpatient treatment and after completion of treatment. Method of measurement: Spirometry machine.;Percent of patients with decreased residual volumes of lungs. Timepoint: Before initiation of outpatient treatment and after completion of treatment. Method of measurement: body box (plethysmograph) machines.;Percent of patients with increased total lung capacities of lungs. Timepoint: Before initiation of outpatient treatment and after completion of treatment. Method of measurement: body box (plethysmograph) machines.;Percent of patients with decreased airway resistance. Timepoint: Before initiation of outpatient treatment and after completion of treatment. Method of measurement: Impulse oscillometry machine.
- Secondary Outcome Measures
Name Time Method